Patent Assignment
Reel/Frame 029499/0087
Security Agreement
Recorded: 2012-12-19
Pages: 21
Assignor
AMARIN PHARMACEUTICALS IRELAND LIMITED
Executed: 2012-12-19
Assignee
BIOPHARMA SECURED DEBT FUND II HOLDINGS CAYMAN LP
WALKER HOUSE, 87 MARY STREET, C/O WALKERS CORPORATE SERVICES LIMITED, GEORGE TOWN, GRAND CAYMAN, KY1-9005, CAYMAN ISLANDS
Covered Properties
(65)
Therapeutic Combinations of Fatty Acids
Patent:
6,479,544 →
Application:
09/893,473 →
Highly Purified Ethyl Epa and Other Epa Derivatives
Methods of Treating Hypertriglyceridemia
Stable Pharmaceutical Composition and Methods of Using Same
Compositions and Methods for Lowering Triglycerides Without Raising Ldl-C Levels in a Subject on Concomitant Statin Therapy
Pharmaceutical Composition Comprising Omega-3 Fatty Acid and Hydroxy-Derivative of a Statin and Methods of Using Same
Application:
12/888,994 →
Publication:
US 2011/0071176
Highly Purified Ethyl Epa and Other Epa Derivatives
Application:
12/951,620 →
Publication:
US 2011/0065793
Compositions and Methods for Treating and/or Preventing Cardiovascular Disease
Application:
13/040,977 →
Publication:
US 2011/0218243
Pharmaceutical Composition Comprising Eicosapentaenoic Acid and Nicotinic Acid and Methods of Using Same
Application:
13/061,865 →
Publication:
US 2011/0236476
Pharmaceutical Compositions Comprising Epa and a Cardiovascular Agent and Methods of Using the Same
Application:
13/124,628 →
Publication:
US 2012/0093922
Methods of Treating Hypertriglyceridemia
Application:
13/198,221 →
Publication:
US 2011/0288171
Pharmaceutical Compositions Comprising Epa and a Cardiovascular Agent and Methods of Using the Same
Stable Pharmaceutical Composition and Methods of Using Same
Application:
13/266,374 →
Publication:
US 2012/0100208
Compositions and Methods for Lowering Triglycerides
Methods of Treating Hypertriglyceridemia
Methods of Treating Hypertriglyceridemia
Methods of Treating Hypertriglyceridemia
Methods of Treating Hypertriglyceridemia
Methods of Treating Hypertriglyceridemia
Compositions and Methods for Lowering Triglycerides Without Raising Ldl-C Levels in a Subject on Concomitant Statin Therapy
Application:
13/359,114 →
Publication:
US 2013/0012580
Methods of Treating Hypertriglyceridemia
Application:
13/403,694 →
Publication:
US 2012/0156285
Compositions and Methods for Lowering Triglycerides in a Subject on Concomitant Statin Therapy
Methods of Treating Hypertriglyceridemia
Application:
13/404,666 →
Publication:
US 2012/0157530
Compositions and Methods for Lowering Triglycerides
Application:
13/404,686 →
Publication:
US 2012/0157531
Methods for Lowering Triglycerides Without Raising Ldl-C Levels in a Subject on Concomitant Statin Therapy
Pharmaceutical Compositions Comprising Epa and a Cardiovascular Agent and Methods of Using the Same
Application:
13/418,591 →
Publication:
US 2012/0172432
Highly Purified Ethyl Epa and Other Epa Derivatives
Application:
13/439,392 →
Publication:
US 2012/0195963
Stable Pharmaceutical Composition and Methods of Using Same
Methods of Treating Hypertriglyceridemia
Application:
13/482,720 →
Publication:
US 2012/0237594
Methods of Treating Mixed Dyslipidemia
Methods of Treating Hypertriglyceridemia
Methods of Treating Hypertriglyceridemia
Methods of Treating Hypertriglyceridemia
Methods of Treating Hypertriglyceridemia
Stable Pharmaceutical Composition and Methods of Using Same
Stable Pharmaceutical Composition and Methods of Using Same
Stable Pharmaceutical Composition and Methods of Using Same
Methods of Treating Hypertriglyceridemia
Methods of Treating Hypertriglyceridemia
Application:
13/671,197 →
Publication:
US 2013/0131170
Stable Pharmaceutical Composition and Methods of Using Same
Stable Pharmaceutical Composition and Methods of Using Same
Pharmaceutical Composition Comprising Eicosapentaenoic Acid and Nicotinic Acid and Methods of Using Same
Methods of Treating Hypertriglyceridemia
Methods of Treating Hypertriglyceridemia
Pharmaceutical Composition Comprising Eicosapentaenoic Acid and Low Dose Nicotinic and Methods of Using Same
Application:
61/093,506 →
Methods of Treating and/or Preventing Cardiovascular Diseases and Disorders
Application:
61/151,291 →
Methods of Treating Hypertriglyceridemia
Application:
61/173,755 →
Pharmaceutical Compositions Comprising Epa and a Cardiovascular Agent and Methods of Using the Same
Application:
61/173,759 →
Stable Pharmaceutical Composition and Methods of Using Same
Application:
61/173,763 →
Compositions and Methods for Lowering Triglycerides Without Raising Ldl-C Levels in a Subject on Concomitant Statin Therapy
Application:
61/187,132 →
Pharmaceutical Composition Comprising Omega-3 Fatty Acid and Hydroxy-Derivative of a Statin and Methods of Using Same
Application:
61/245,086 →
Compositions and Methods for Treating and/or Preventing Cardiovascular Disease
Application:
61/310,443 →
Low Eructation Composition and Methods for Treating and/or Preventing Cardiovascular Disease in a Subject with Fish Allergy/Hypersensitivity
Application:
61/417,691 →
Methods of Treating Hypertriglyceridemia
Application:
61/556,573 →
Compositions and Methods for Lowering Levels of High-Sensitivity (Hs-Crp) in a Subject
Application:
61/584,013 →
Pharmaceutical Composition Comprising Omega-3 Fatty Acid and Hydroxy-Derivative of a Statin and Methods of Using Same
Application:
61/655,879 →
Methods of Treating Hypercholesterolemia
Application:
61/655,890 →
Compositions and Methods for Lowering Levels of High-Sensitivity C-Reactive Protein (Hs-Crp) in a Subject
Application:
61/656,347 →
Methods of Treating Cardiovscular Disease in Statin-Intolerant Subjects
Application:
61/666,428 →
Methods of Reducing Ldl-P
Application:
61/666,433 →
Methods of Treating Pediatric Metabolic Syndrome
Application:
61/666,437 →
Methods of Treating Hypertriglyceridemia
Application:
61/666,442 →
Methods of Reducing the Risk of a Cardiovascular Event in a Subject on Statin Therapy
Application:
61/666,447 →
Methods of Treating Hypertriglyceridemia
Application:
61/670,408 →
Compositions and Methods for Lowering Triglycerides Without Raising Ldl-C Levels in a Subject on Concomitant Statin Therapy
Application:
61/723,108 →
Related Assignments
(13)
Other recorded transfers of the patents in this record — the chain of ownership.
Proof of Ownership of Shares
May 25, 2012
From: AMARIN NEUROSCIENCE LIMITED
To: AMARIN CORPORATION PLC
Reel/Frame 028275/0333 →
Change of Name
May 25, 2012
From: LAXDALE LIMITED
To: AMARIN NEUROSCIENCE LIMITED
Reel/Frame 028275/0763 →
Assignment of Assignor's Interest
May 25, 2012
From: PEET, MALCOLM; VADDADI, KRISHNA S.
To: LAXDALE LIMITED
Reel/Frame 028270/0071 →
Assignment of Assignor's Interest
May 30, 2012
From: MANKU, MEHAR; ROWE, JONATHAN
To: AMARIN CORPORATION PLC.
Reel/Frame 028291/0129 →
Assignment of Assignor's Interest
May 30, 2012
From: MANKU, MEHAR
To: AMARIN CORPORATION PLC.
Reel/Frame 028291/0058 →
Assignment of Assignor's Interest
May 30, 2012
From: ROWE, JONATHAN
To: AMARIN PHARMA, INC.
Reel/Frame 028291/0077 →
Assignment of Assignor's Interest
May 31, 2012
From: AMARIN PHARMA INC.
To: AMARIN PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 028295/0491 →
Assignment of Assignor's Interest
May 31, 2012
From: AMARIN CORPORATION PLC
To: AMARIN PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 028295/0289 →
Patent Security Assignment and Assumption Agreement
Dec 20, 2017
From: BIOPHARMA SECURED DEBT FUND II HOLDINGS CAYMAN LP
To: CPPIB CREDIT EUROPE S.À R.L.
Reel/Frame 044956/0395 →
Security Interest
Dec 21, 2017
From: AMARIN PHARMACEUTICALS IRELAND LIMITED
To: CPPIB CREDIT EUROPE S.À R.L.
Reel/Frame 044938/0257 →
Change of Address of Assignee
Aug 27, 2020
From: AMARIN PHARMA, INC.
To: AMARIN PHARMA, INC.
Reel/Frame 053611/0324 →
Release of Security Interest
Nov 19, 2020
From: CPPIB CREDIT EUROPE S.À R.L.
To: AMARIN PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 054484/0552 →
Assignment of Assignor's Interest
May 15, 2024
From: SONI, PARESH; OSTERLOH, IAN
To: AMARIN PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 067418/0613 →